- Home
- GDRX
GDRX
GoodRx Holdings Inc.
as 11-15-2024 4:00pm EST
GoodRx Holdings Inc is a consumer-focused digital healthcare platform that aims to lower the cost of healthcare in the United States. It operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and provides access to negotiated prices through codes that can be used to save money on prescriptions across the United States. GoodRx generates revenue from core business from pharmacy benefit managers (PBMs) that manage formularies and prescription transactions including establishing pricing between consumers and pharmacies. It also offers various healthcare products and services, including pharma manufacturer solutions, subscriptions, and telehealth services.
| Founded: | 2011 | Country: | United States |
| Employees: | N/A | City: | SANTA MONICA |
| Market Cap: | 3.1B | IPO Year: | 2020 |
| Target Price: | $9.03 | AVG Volume (30 days): | 1.8M |
| Analyst Decision: | Buy | Number of Analysts: | 16 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.05 | EPS Growth: | N/A |
| 52 Week Low/High: | $4.09 - $9.26 | Next Earning Date: | 11-07-2024 |
| Revenue: | $790,385,000 | Revenue Growth: | 7.14% |
| Revenue Growth (this year): | 8.5% | Revenue Growth (next year): | 7.95% |
Stock Insider Trading Activity of GoodRx Holdings Inc. (GDRX)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Spectrum Equity VII, L.P. | GDRX | 10% Owner | Aug 29 '24 | Sell | $7.86 | 10,677 | $83,922.29 | 0 |
Latest GoodRx Holdings Inc. News
GDRX Breaking Stock News: Dive into GDRX Ticker-Specific Updates for Smart Investing
MT Newswires
6 days ago
UBS Adjusts GoodRx Price Target to $6 From $8.50, Maintains Neutral Rating
Simply Wall St.
6 days ago
GoodRx Holdings Third Quarter 2024 Earnings: EPS Misses Expectations
MT Newswires
9 days ago
RBC Capital Cuts Price Target on GoodRx Holdings to $8.50 From $10, Maintains Outperform Rating
MT Newswires
9 days ago
Deutsche Bank Adjusts GoodRx Price Target to $8 From $9, Maintains Hold Rating
MT Newswires
9 days ago
Morgan Stanley Adjusts GoodRx Holdings' Price Target to $7 From $9.50, Keeps Equalweight Rating
Motley Fool
9 days ago
Why GoodRx Holdings Stock Was Sinking This Week
GuruFocus.com
9 days ago
GoodRx Holdings Inc (GDRX) Q3 2024 Earnings Call Highlights: Strong Financial Performance ...
Motley Fool
9 days ago
GoodRx (GDRX) Q3 2024 Earnings Call Transcript
Compare GDRX vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "GDRX GoodRx Holdings Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.